Artemis Investment Management LLP Sells 39,188 Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG)

Artemis Investment Management LLP decreased its stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 42.1% during the 4th quarter, according to the company in its most recent filing with the SEC. The firm owned 53,789 shares of the medical equipment provider’s stock after selling 39,188 shares during the quarter. Artemis Investment Management LLP’s holdings in Intuitive Surgical were worth $28,076,000 as of its most recent filing with the SEC.

A number of other large investors have also made changes to their positions in ISRG. Intech Investment Management LLC lifted its position in shares of Intuitive Surgical by 6.2% in the 2nd quarter. Intech Investment Management LLC now owns 21,279 shares of the medical equipment provider’s stock worth $9,466,000 after acquiring an additional 1,244 shares during the period. Benjamin F. Edwards & Company Inc. raised its stake in shares of Intuitive Surgical by 5.5% in the second quarter. Benjamin F. Edwards & Company Inc. now owns 6,450 shares of the medical equipment provider’s stock valued at $2,870,000 after purchasing an additional 338 shares in the last quarter. King Luther Capital Management Corp lifted its position in Intuitive Surgical by 2.1% in the second quarter. King Luther Capital Management Corp now owns 5,670 shares of the medical equipment provider’s stock worth $2,522,000 after purchasing an additional 114 shares during the period. AE Wealth Management LLC lifted its position in Intuitive Surgical by 24.5% in the second quarter. AE Wealth Management LLC now owns 3,822 shares of the medical equipment provider’s stock worth $1,700,000 after purchasing an additional 752 shares during the period. Finally, Sei Investments Co. increased its holdings in Intuitive Surgical by 1.4% in the 2nd quarter. Sei Investments Co. now owns 527,686 shares of the medical equipment provider’s stock valued at $234,734,000 after buying an additional 7,080 shares during the period. Institutional investors and hedge funds own 83.64% of the company’s stock.

Analyst Ratings Changes

ISRG has been the subject of a number of analyst reports. Oppenheimer reaffirmed a “market perform” rating on shares of Intuitive Surgical in a report on Friday, October 18th. Raymond James raised their price target on shares of Intuitive Surgical from $500.00 to $540.00 and gave the stock an “outperform” rating in a research note on Monday, October 14th. BTIG Research upped their price objective on Intuitive Surgical from $535.00 to $561.00 and gave the company a “buy” rating in a research note on Tuesday, November 26th. Mizuho increased their target price on Intuitive Surgical from $440.00 to $500.00 in a report on Thursday, October 17th. Finally, Citigroup boosted their price target on Intuitive Surgical from $567.00 to $640.00 and gave the company a “buy” rating in a research note on Wednesday, December 11th. One investment analyst has rated the stock with a sell rating, four have assigned a hold rating and fifteen have assigned a buy rating to the company. Based on data from MarketBeat, Intuitive Surgical has an average rating of “Moderate Buy” and a consensus price target of $554.17.

Insider Transactions at Intuitive Surgical

In other Intuitive Surgical news, EVP Brian Edward Miller sold 2,553 shares of the company’s stock in a transaction that occurred on Tuesday, October 22nd. The shares were sold at an average price of $515.00, for a total value of $1,314,795.00. Following the completion of the sale, the executive vice president now owns 7,066 shares of the company’s stock, valued at approximately $3,638,990. This represents a 26.54 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, CFO Jamie Samath sold 270 shares of Intuitive Surgical stock in a transaction on Tuesday, December 10th. The stock was sold at an average price of $540.15, for a total transaction of $145,840.50. Following the transaction, the chief financial officer now directly owns 8,757 shares in the company, valued at approximately $4,730,093.55. This represents a 2.99 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 48,190 shares of company stock worth $25,012,927 in the last three months. Insiders own 0.80% of the company’s stock.

Intuitive Surgical Price Performance

Shares of NASDAQ:ISRG opened at $592.64 on Friday. The stock has a market cap of $211.09 billion, a price-to-earnings ratio of 95.28, a P/E/G ratio of 4.66 and a beta of 1.39. The company has a 50 day moving average of $540.66 and a 200-day moving average of $498.77. Intuitive Surgical, Inc. has a one year low of $362.14 and a one year high of $597.68.

Intuitive Surgical (NASDAQ:ISRG) last released its earnings results on Thursday, October 17th. The medical equipment provider reported $1.56 EPS for the quarter, topping analysts’ consensus estimates of $1.24 by $0.32. The firm had revenue of $2.04 billion during the quarter, compared to analyst estimates of $2.01 billion. Intuitive Surgical had a net margin of 28.51% and a return on equity of 13.41%. Equities research analysts anticipate that Intuitive Surgical, Inc. will post 5.45 earnings per share for the current year.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.